Proteomics Intl Labs Ltd has released a press release.
PromarkerD US commercialisation & Promarker pipeline update
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Earlier from Proteomics International Laboratories
- European patent granted for OxiDx technology
- Study validates biomarkers for oesophageal cancer blood test
- Study validates biomarkers for endometriosis blood test
- Proteomics to raise $6.5m through Institutional Placement
- December 2023 Quarterly Activities Report and Appendix 4C
Later from Proteomics International Laboratories
- Proteomics signs with Oxford Univ to validate test for Endo
- March 2024 Quarterly Activities Report and Appendix 4C
- Proteomics appoints medical devices sales agency for Europe
- Eurobio Scientific to sell PromarkerD DKD test in France
- June 2024 Quarterly Activities Report and Appendix 4C
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories